These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2361757)

  • 21. Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.
    McIlleron H; Willemse M; Werely CJ; Hussey GD; Schaaf HS; Smith PJ; Donald PR
    Clin Infect Dis; 2009 Jun; 48(11):1547-53. PubMed ID: 19392636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isoniazid acetylation in Gilbert's syndrome].
    Pereira-Filho RA; Sevá-Pereira A; de Magalhães AF
    Arq Gastroenterol; 1985; 22(4):172-5. PubMed ID: 3837656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics.
    Weber WW; Miceli JN; Hearse DJ; Drummond GS
    Drug Metab Dispos; 1976; 4(1):94-101. PubMed ID: 3408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
    Lauterburg BH; Smith CV; Todd EL; Mitchell JR
    J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population screening for isoniazid acetylator phenotype.
    Seifart HI; Parkin DP; Botha FJ; Donald PR; Van Der Walt BJ
    Pharmacoepidemiol Drug Saf; 2001; 10(2):127-34. PubMed ID: 11499851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of the phenotype of N-acetyltransferase activity].
    Bulovskaia LN; Borisenko GN; Drobachenko OA; Kurbatova GP; Ivanova VV
    Lab Delo; 1990; (10):28-30. PubMed ID: 1704451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a new method for phenotyping of slow and rapid acetylators.
    Hodgkin MM; Hsu AH; Varughese P; Eidus L
    Int J Clin Pharmacol; 1973 Jul; 7(4):355-62. PubMed ID: 4726281
    [No Abstract]   [Full Text] [Related]  

  • 29. [The pharmacokinetics of isoniazid in children (author's transl)].
    Advenier C; Saint-Aubin A; Scheinmann P; Paupe J
    Rev Fr Mal Respir; 1981; 9(5):365-74. PubMed ID: 7323401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation].
    Miscoria G; Leneveu A; Walle C; Roux A
    Ann Biol Clin (Paris); 1988; 46(9):734-40. PubMed ID: 3223632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbit.
    Hein DW; Weber WW
    J Pharmacol Exp Ther; 1984 Mar; 228(3):588-92. PubMed ID: 6707910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of human lymphocyte N-acetyltransferase and its relationship to the isoniazid acetylator polymorphism.
    McQueen CA; Weber WW
    Biochem Genet; 1980 Oct; 18(9-10):889-904. PubMed ID: 7225085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of the rapid isoniazid acetylator phenotype in Lagos (Nigeria).
    Odeigah PG; Okunowo MA
    Hum Hered; 1989; 39(1):26-31. PubMed ID: 2759621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators.
    O'Shea D; Kim RB; Wilkinson GR
    Br J Clin Pharmacol; 1997 Jan; 43(1):99-103. PubMed ID: 9056059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of coadministration of procainamide and isoniazid on each other's acetylation pathway.
    Schneck DW; Sprouse JS; Shiroff RA; Vary JE; DeWitt FO; Hayes AH
    Pharmacology; 1979; 18(1):34-41. PubMed ID: 419159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylator phenotype in Iraqi patients with atopic dermatitis.
    Najim RA; Al-Waiz MM; Al-Razzuqi RA
    Dermatol Online J; 2006 Dec; 12(7):1. PubMed ID: 17459287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic interaction of simultaneously administered isoniazid and phenytoin in patients with tuberculous meningitis or tuberculoma having seizures.
    Adole PS; Singh A; Kharbanda PS; Sharma S
    Eur J Pharmacol; 2013 Aug; 714(1-3):157-62. PubMed ID: 23792142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic polymorphism of isoniazid acetylation in Chilean patients with tuberculosis].
    Ligueros M; Cruz Coke R; Neira S; Saavedra H; Kramer V; Prieto JC; Gelman M; Saavedra A; Nuñez A; Pescio S
    Rev Med Chil; 1989 Dec; 117(12):1339-43. PubMed ID: 2519370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.